glp 1 agonists tirzepatide gip/glp 1-agonist GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes Twincretin drug Tirzepatide shows unmatched

10.1016/j.phrs.2019.104554 32

Choline-containing supplements: Concurrent use with the choline in this formulation may produce additive effects on liver fat metabolism

Saxenda may still have a role for specific patients whose insurance covers it preferentially, who have had previous success with liraglutide, or who have particular reasons to prefer that medication

Compounded semaglutide was first introduced and patented in 2016, and FDA-approved as a type 2 diabetes treatment in 2017

If symptoms are persistent or significantly restrict dietary intake, referral to a registered dietitian should be considered to ensure nutritional needs continue to be met

Semaglutide slows this process down